Literature DB >> 28921114

Effects of sevoflurane and halothane anesthesia on liver circulation and oxygen metabolism in the dog during hepatolobectomy.

Bu-Wei Yu1, Nobuyuki Matsumoto2.   

Abstract

PURPOSE: Effects of sevoflurane and halothane anesthesia on liver circulation and oxygen metabolism during hepatolobectomy were investigated in the dog, with the aim of choosing a better anesthetic for hepatic resection.
METHODS: Sixteen mongrel dogs were randomly divided into two groups with eight in each. Electromagnetic flowmeters were used to measure hepatic arterial and portal venous blood flows (1) before the inhalation of each anesthetic (base line); (2) 1 h after the start of inhalation of 1.5 minimum alveolar concentration (MAC) anesthetic; (3) 1 h after hepatolobectomy with the same MAC of anesthesia; and (4) 2 h after the discontinuation of anesthesia. Measurements of systemic hemodynamics, blood gas tensions, plasma enzyme leaks and arterial ketone body ratio were made at the same time.
RESULTS: Sevoflurane maintained hepatic arterial blood flow better than halothane anesthesia, both before and after hepatolobectomy. Hepatic arterial vascular resistance increased in the halothane group but did not change in the sevoflurane group after hepatolobectomy. No significant difference was found in oxygen metabolism and arterial ketone body ratio between two groups. Serum enzyme leakage was less in the sevoflurane group.
CONCLUSION: Sevoflurane has less adverse effects on liver circulation, especially hepatic arterial blood flow, and hepatic function than halothane in the case of hepatolobectomy.

Entities:  

Keywords:  Halothane; Hepatic circulation; Hepatolobectomy; Inhalation anesthetic; Sevoflurane

Year:  1997        PMID: 28921114     DOI: 10.1007/BF02480040

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  16 in total

1.  The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs.

Authors:  E J Frink; S E Morgan; A Coetzee; P F Conzen; B R Brown
Journal:  Anesthesiology       Date:  1992-01       Impact factor: 7.892

2.  Disturbances in hepatic blood flow during anesthesia and surgery.

Authors:  S I Gelman
Journal:  Arch Surg       Date:  1976-08

3.  Effects of certain i.v. anaesthetics on liver blood flow and hepatic oxygen consumption in the greyhound.

Authors:  I A Thomson; W Fitch; R L Hughes; D Campbell; R Watson
Journal:  Br J Anaesth       Date:  1986-01       Impact factor: 9.166

Review 4.  Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response.

Authors:  W W Lautt
Journal:  Am J Physiol       Date:  1985-11

Review 5.  General anesthesia and hepatic circulation.

Authors:  S Gelman
Journal:  Can J Physiol Pharmacol       Date:  1987-08       Impact factor: 2.273

6.  Effect of increased concentrations of carbon dioxide during halothane anaesthesia on liver blood flow and hepatic oxygen consumption.

Authors:  I A Thomson; W Fitch; R L Hughes; D Campbell
Journal:  Br J Anaesth       Date:  1983-12       Impact factor: 9.166

7.  The different responses of the hepatic arterial bed to hypovolaemia and to halothane anaesthesia.

Authors:  M Andreen; L Irestedt; B Zetterström
Journal:  Acta Anaesthesiol Scand       Date:  1977       Impact factor: 2.105

8.  Comparison of the effects of isoflurane and desflurane on cardiovascular dynamics and regional blood flow in the chronically instrumented dog.

Authors:  R G Merin; J M Bernard; M F Doursout; M Cohen; J E Chelly
Journal:  Anesthesiology       Date:  1991-03       Impact factor: 7.892

9.  Halothane impairs the hemodynamic influence of endothelium-derived nitric oxide.

Authors:  D H Sigmon; I Florentino-Pineda; R A Van Dyke; W H Beierwaltes
Journal:  Anesthesiology       Date:  1995-01       Impact factor: 7.892

10.  Effects of enflurane and halothane on liver blood flow and oxygen consumption in the greyhound.

Authors:  R L Hughes; D Campbell; W Fitch
Journal:  Br J Anaesth       Date:  1980-11       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.